Giá của Psyence Biomedical Ltd. là bao nhiêu (PBM)

Giá của Psyence Biomedical Ltd. (PBM) là $3.20

Mũ thị trường của Psyence Biomedical Ltd. là gì (PBM)

Giới hạn thị trường của Psyence Biomedical Ltd. (PBM) là $60.86K

Psyence Biomedical Ltd. (PBM) Giá và Vốn Hóa Thị Trường

Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.

Giá của PBM	Tài sản B	Thị trường của B	Kết quả
$286,436,535 $60.86K	NVDA	$5.448T	+8,951,141,613.39%
$232,577,486 $60.86K	AAPL	$4.423T	+7,268,046,333.40%
$218,748,062 $60.86K	GOOG	$4.160T	+6,835,876,850.49%
$192,613,746 $60.86K	MSFT	$3.663T	+6,019,179,465.50%
$152,017,919 $60.86K	AMZN	$2.891T	+4,750,559,858.79%

Giá của PBM

Tài sản B

Thị trường của B

Kết quả

$286,436,535 $60.86K